IP Library Granted Patent US 9,168,261
Granted Patent B2
US 9,168,261 · App. 13/931,572 · Granted Oct 27, 2015

Compositions and methods for cartilage repair

Inventor: Christopher J. Centeno (Broomfield, CO)
Assignee: Regenerative Sciences, LLC
A61K31/56A61K31/19A61K31/375A61K31/573A61K31/7088A61K35/16A61K35/19A61K35/28A61K38/1825A61K38/1841A61K38/1875A61K38/2006A61K38/363A61K45/06A61L2300/222
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,168,261
App. No.
13/931,572
Granted
Oct 27, 2015
Kind
B2
Abstract

Autologous compositions and methods are provided for cartilage repair in patients in need thereof. Some aspects include combinations of platelet-based materials with chondrogenesis inducing agents in the presence or absence of cell-based therapies.

Claims (12)

1. A method for facilitating cartilage repair in a patient in need thereof comprising:

obtaining platelets from the patient;

preparing a 5% to 40% platelet lysate solution from the platelets, wherein said platelet lysate solution is prepared by freeze-thawing the platelets obtained from the patient;

obtaining autologous mesenchymal stem cells (MSCs) from bone marrow, peripheral blood, or adipose tissue of the patient;

obtaining one or more chondrogenesis inducing agents; and

administering the MSCs, the 5% to 40% platelet lysate solution and the one or more chondrogenesis inducing agents to a site in the patient in need of cartilage repair;

wherein the combined administration of the MSCs, the 5% to 40% platelet lysate solution and the one or more chondrogenesis inducing agents facilitates cartilage repair at the site in the patient in need of repair, and wherein at least one of the chondrogenesis inducing agents is a corticosteroid.

2. The method of claim 1 , further comprising administering a platelet rich plasma, platelet rich fibrin, whole cell platelet or a mixture thereof to the patient in need thereof, and wherein the administration is at the site in the patient in need of repair.

3. The method of claim 1 wherein the administering step further comprises administering a carrier material comprising a gel, hydrogel, or foam.

4. The method of claim 1 , wherein the corticosteroid is dexamethasone.

5. The method of claim 1 , wherein the MSCs, the 5% to 40% platelet lysate solution and the corticosteroid are combined prior to administration to the patient.

6. The method of claim 1 , wherein the corticosteroid and the 5% to 40% platelet lysate solution are combined prior to administration to the patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2018
From: REGENERATIVE SCIENCES, LLC.
To: REGENEXX, LLC.
Reel/Frame 045961/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2014
From: CENTENO, CHRISTOPHER J
To: REGENERATIVE SCIENCES, LLC
Reel/Frame 032090/0467 →
Continuity (3)
Continuation 12922436
Provisional Application 61036551 · Mar 14, 2008
Related Publication 20130287753A1 · Oct 31, 2013